Judges Scientific, a group involved in the buy and build of scientific instrument businesses, gives below the information required by Schedule 6 of the AIM Rules for Companies in connection with the Judges Scientific plc Share Option Schemes.
Name of applicant:
Judges Scientific plc
Name of scheme:
Judges' Approved and Unapproved Share Option Schemes
Period of return:
4 June 2019
15 November 2019
Balance under scheme from previous return:
32,108 Ordinary Shares
The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:
Number of securities issued/allotted under scheme during period:
4,650 Ordinary Shares
Balance under scheme not yet issued/allotted at end of period
27,458 Ordinary Shares
Number and class of securities originally listed and the date of admission
100,000 Ordinary Shares on 13 May 2015, a further 100,000 Ordinary Shares on 24 January 2018
Total number of securities in issue at the end of the period
Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...